The genes identified in this study (CDKN1A, HIF1A, MXD1, and SOD2) were significantly upregulated in lung tissues in two different clinical COPD transcriptomics datasets, and had the potential to develop as therapeutics targets of COPD. This evidence concerns the gene MXD1 and chronic obstructive pulmonary disease.